Literature DB >> 33613155

Pentadecanoic acid promotes basal and insulin-stimulated glucose uptake in C2C12 myotubes.

Wen-Cheng Fu1, Hai-Yan Li1, Tian-Tian Li1, Kuo Yang1, Jia-Xiang Chen1, Si-Jia Wang1, Chun-Hui Liu2, Wen Zhang1.   

Abstract

BACKGROUND: Saturated fatty acids (SFAs) generally have been thought to worsen insulin-resistance and increase the risk of developing type 2 diabetes mellitus (T2DM). Recently, accumulating evidence has revealed that SFAs are not a single homogeneous group, instead different SFAs are associated with T2DM in opposing directions. Pentadecanoic acid (C15:0, PA) is directly correlated with dairy products, and a negative association between circulating PA and metabolic disease risk was observed in epidemiological studies. Therefore, the role of PA in human health needs to be reinforced. Whether PA has a direct benefit on glucose metabolism and insulin sensitivity needs further investigation.
OBJECTIVE: The present study aimed to investigate the effect and potential mechanism of action of PA on basal and insulin stimulated glucose uptake in C2C12 myotubes.
METHODS: Glucose uptake was determined using a 2-(N-[7-nitrobenz-2-oxa-1,3-diazol-4-yl] amino)-2-deoxyglucose (2-NBDG) uptake assay. Cell membrane proteins were isolated and glucose transporter 4 (GLUT4) protein was detected by western blotting to examine the translocation of GLUT4 to the plasma membrane. The phosphorylation levels of proteins involved in the insulin and 5'-adenosine monophosphate-activated protein kinase (AMPK) pathways were examined by western blotting.
RESULTS: We found that PA significantly promoted glucose uptake and GLUT4 translocation to the plasma membrane. PA had no effect on the insulin-dependent pathway involving insulin receptor substrate 1 (Tyr632) and protein kinase B (PKB/Akt), but increased phosphorylation of AMPK and Akt substrate of 160 kDa (AS160). Compound C (an AMPK inhibitor) blocked PA-induced AMPK activation and reversed PA-induced GLUT4 translocation, indicating that PA promotes glucose uptake via the AMPK pathway in vitro. Moreover, PA significantly promoted insulin-stimulated glucose uptake in myotubes. Under insulin stimulation, PA did not affect the insulin-dependent pathway, but still activated AMPK.
CONCLUSION: PA, an odd-chain SFA, significantly stimulates glucose uptake via the AMPK-AS160 pathway and exhibits an insulin-sensitizing effect in myotubes. © Fu et al.

Entities:  

Keywords:  AMP-activated protein kinase; C2C12 myotubes; glucose uptake; insulin sensitivity; pentadecanoic acid

Year:  2021        PMID: 33613155      PMCID: PMC7869443          DOI: 10.29219/fnr.v65.4527

Source DB:  PubMed          Journal:  Food Nutr Res        ISSN: 1654-661X            Impact factor:   3.894


  21 in total

Review 1.  The insulin signalling pathway.

Authors:  Jose M Lizcano; Dario R Alessi
Journal:  Curr Biol       Date:  2002-04-02       Impact factor: 10.834

2.  Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein.

Authors:  Lorena Eguez; Adrian Lee; Jose A Chavez; Cristinel P Miinea; Susan Kane; Gustav E Lienhard; Timothy E McGraw
Journal:  Cell Metab       Date:  2005-10       Impact factor: 27.287

3.  The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic.

Authors:  Farah S L Thong; Philip J Bilan; Amira Klip
Journal:  Diabetes       Date:  2007-02       Impact factor: 9.461

4.  Saturated fatty acids and type 2 diabetes: more evidence to re-invent dietary guidelines.

Authors:  Dariush Mozaffarian
Journal:  Lancet Diabetes Endocrinol       Date:  2014-08-05       Impact factor: 32.069

5.  Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle.

Authors:  Eric B Taylor; Ding An; Henning F Kramer; Haiyan Yu; Nobuharu L Fujii; Katja S C Roeckl; Nicole Bowles; Michael F Hirshman; Jianxin Xie; Edward P Feener; Laurie J Goodyear
Journal:  J Biol Chem       Date:  2008-02-13       Impact factor: 5.157

6.  Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.

Authors:  L Salvadó; T Coll; A M Gómez-Foix; E Salmerón; E Barroso; X Palomer; M Vázquez-Carrera
Journal:  Diabetologia       Date:  2013-03-05       Impact factor: 10.122

7.  Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus.

Authors:  Benno Krachler; Margareta Norberg; Jan W Eriksson; Göran Hallmans; Ingegerd Johansson; Bengt Vessby; Lars Weinehall; Bernt Lindahl
Journal:  Nutr Metab Cardiovasc Dis       Date:  2007-11-26       Impact factor: 4.222

Review 8.  Dietary fat, insulin sensitivity and the metabolic syndrome.

Authors:  G Riccardi; R Giacco; A A Rivellese
Journal:  Clin Nutr       Date:  2004-08       Impact factor: 7.324

9.  Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.

Authors:  Nita G Forouhi; Albert Koulman; Stephen J Sharp; Fumiaki Imamura; Janine Kröger; Matthias B Schulze; Francesca L Crowe; José María Huerta; Marcela Guevara; Joline W J Beulens; Geertruida J van Woudenbergh; Laura Wang; Keith Summerhill; Julian L Griffin; Edith J M Feskens; Pilar Amiano; Heiner Boeing; Françoise Clavel-Chapelon; Laureen Dartois; Guy Fagherazzi; Paul W Franks; Carlos Gonzalez; Marianne Uhre Jakobsen; Rudolf Kaaks; Timothy J Key; Kay-Tee Khaw; Tilman Kühn; Amalia Mattiello; Peter M Nilsson; Kim Overvad; Valeria Pala; Domenico Palli; J Ramón Quirós; Olov Rolandsson; Nina Roswall; Carlotta Sacerdote; María-José Sánchez; Nadia Slimani; Annemieke M W Spijkerman; Anne Tjonneland; Maria-José Tormo; Rosario Tumino; Daphne L van der A; Yvonne T van der Schouw; Claudia Langenberg; Elio Riboli; Nicholas J Wareham
Journal:  Lancet Diabetes Endocrinol       Date:  2014-08-05       Impact factor: 32.069

Review 10.  A review of odd-chain fatty acid metabolism and the role of pentadecanoic Acid (c15:0) and heptadecanoic Acid (c17:0) in health and disease.

Authors:  Benjamin Jenkins; James A West; Albert Koulman
Journal:  Molecules       Date:  2015-01-30       Impact factor: 4.411

View more
  3 in total

1.  Broader and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid across twelve primary human cell-based disease systems.

Authors:  Stephanie K Venn-Watson; Camden N Butterworth
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

2.  Effect of High-Fat and Low-Fat Dairy Products on Cardiometabolic Risk Factors and Immune Function in a Low Birthweight Swine Model of Diet-Induced Insulin Resistance.

Authors:  Yongbo She; Kun Wang; Alexander Makarowski; Rabban Mangat; Sue Tsai; Benjamin P Willing; Spencer D Proctor; Caroline Richard
Journal:  Front Nutr       Date:  2022-06-17

3.  Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health.

Authors:  Stephanie Venn-Watson; John Reiner; Eric D Jensen
Journal:  Sci Rep       Date:  2022-08-23       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.